# Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)

> **NCT02267304** · PHASE2 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 37 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 50 mL of sodium chloride (0,9%)
- **DRUG:** Morphine 0,05mg/kg
- **DRUG:** Naloxone 10mg

## Key facts

- **NCT ID:** NCT02267304
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-30
- **Primary completion:** 2016-08
- **Final completion:** 2016-08-30
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2021-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267304, "Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Morphine and Naloxone on Motivation (MBBAnalgesic)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02267304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*